ADIAL PHARMACEUTICALS, INC.

Adial Pharmaceuticals plans leadership changes tied to annual meeting vote

Adial Pharmaceuticals Plans Major Leadership and Board Transition

Form 8K Adial Pharmaceuticals Inc For: 13 August By Investing.com

Adial Pharmaceuticals announces annual shareholder meeting

Adial Pharmaceuticals (NASDAQ: ADIL) outlines Azora merger, heavy dilution and $53M share overhang

Adial Pharmaceuticals Inc expected to post a loss of $1.03 a share - Earnings Preview

Adial Pharmaceuticals, Inc Revenue Breakdown – NASDAQ:ADIL

Coastlands Capital (NASDAQ: ADIL) buys 3,233 ADIAL shares in open market

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Adial closes $32 million financing, grants stock to new executives

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update